Anthem Biosciences Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26
Revenue	540	550	423	611	418
Other income	23	48	34	51	25
Segment revenue (incl. inter-segment)	-	550	423	611	418
Expenses	377	369	301	385	299
Cost of materials consumed	162	201	185	165	149
Change in inventories	69	22	-42	50	-2
Employee benefit expense	72	68	71	73	79
Finance costs	2	3	0.30	2	0.90
Depreciation & amortisation	26	34	35	40	30
Other expenses	46	41	53	56	43
EBITDA	214	267	165	320	176
EBIT	188	233	130	280	146
Operating profit	-	327	281	395	272
Exceptional items	-	-	-25	1	-
Profit Before Tax	186	230	130	278	145
Tax expense	51	56	38	88	25
Deferred tax	0.40	-8	-0.10	-2	-10
Net Profit	136	173	93	190	120
Financial Ratios
Operating Profit Margin	34.74%	59.45%	66.43%	64.65%	65.07%
EBITDA Margin	39.63%	48.45%	38.96%	52.29%	42.08%
Net Profit Margin	25.19%	31.45%	21.94%	31.10%	28.71%
Earnings Per Share (₹)	2.43	3.09	1.65	-	2.13

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.